Orforglipron for women with stress urinary incontinence who are overweight or have obesity
Official title: A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Run by Eli Lilly and Company · NCT07202884 · Data updated 2026-11-12
This trial will test whether orforglipron reduces urine leakage in adult women with stress urinary incontinence who are overweight or have obesity.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | Eli Lilly and Company Industry-sponsored |
| Locations | 120 sites (Birmingham, Alabama and 119 other locations) |
| Status | Recruiting |
| Started | September 30, 2025 |
| Main results expected | March 2028 |
| Study ends | March 2028 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07202884 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women with stress urinary incontinence and a BMI of 27 kg/m2 or higher who are not pregnant, do not have diabetes, have not had recent incontinence surgery or Botox injections, and are willing to attend in-person visits at a study site are ideal candidates.
✕Probably not a fit
Women with type 1 or type 2 diabetes, recent urinary incontinence surgery, recent Botox injections, current medications for urinary incontinence, recent significant weight change, recent anti-obesity drug use, or who are pregnant or breastfeeding are unlikely to be eligible and may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The GZPS master protocol runs two parallel Phase 3 studies (J2A-MC-GZS1 and J2A-MC-GZS2) that randomize adult female participants with stress urinary incontinence and a BMI ≥27 to receive orforglipron or placebo. Participants will take the study medication or placebo and attend visits over about 58 weeks from screening through safety follow-up. Key exclusions include diabetes, recent urinary incontinence surgery, recent Botox or other incontinence treatments, recent large weight changes, recent anti-obesity medication use, and pregnancy or breastfeeding. The trials compare leakage outcomes and safety between orforglipron and placebo to see if the drug reduces stress-related urine loss.
Why it matters
Potential benefit: If successful, it could reduce stress-related urine leakage and improve daily comfort and quality of life for overweight women with SUI.
How similar studies have gone: Previous weight-loss interventions, including some GLP-1–based approaches, have reduced urinary incontinence in other trials, but using orforglipron specifically for SUI is a novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a body mass index (BMI) of 27 kilograms per square meter (kg/m2) or higher at screening * Have a diagnosis of stress urinary incontinence Exclusion Criteria: * Have had urinary incontinence surgery * Have recently received onabotulinumtoxin A (Botox) bladder injections or currently taking medications for urinary incontinence * Have given birth within one year of screening * Have had a change in body weight of more than 11 pounds within 90 days prior to screening * Have used any anti-obesity medication or alternative weight loss remedies within 180 days prior to screening * Have type 1 diabetes, type 2 diabetes, or any other type of diabetes * Have had a cardiovascular health condition within 90 days prior to screening * Are pregnant, intending to be pregnant, breastfeeding, or intending to breastfeed for the duration of the study
Where it's running
-
University of Alabama -The Kirklin Clinic
Birmingham, Alabama, United States Recruiting -
AMR Clinical
Mobile, Alabama, United States Recruiting -
Matrix Clinical Research
Los Angeles, California, United States Recruiting -
Alarcon Urology Center
Montebello, California, United States Recruiting -
Colorado Clinical Research
Lakewood, Colorado, United States Recruiting -
AMR Clinical
Fort Myers, Florida, United States Recruiting
Show 44 more locations
-
Altus Research
Lake Worth, Florida, United States Recruiting -
New Age Medical Research Corporation
Miami, Florida, United States Recruiting -
Emerald Coast OBGYN Clinical Research
Panama City, Florida, United States Recruiting -
Teak Research Consults
Lawrenceville, Georgia, United States Recruiting -
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, United States Recruiting -
OB/GYN Associates of Erie
Erie, Pennsylvania, United States Recruiting -
Next Level Urgent Care
Houston, Texas, United States Recruiting -
Innovative Medical Research of Texas
Houston, Texas, United States Recruiting -
Health Research of Hampton Roads, Inc.
Newport News, Virginia, United States Recruiting -
Urology of Virginia
Virginia Beach, Virginia, United States Recruiting -
Northwest Clinical Research Center
Bellevue, Washington, United States Recruiting -
Seattle Clinical Research Center
Seattle, Washington, United States Recruiting -
OCT Research ULC
Kelowna, Canada Recruiting -
Kelowna Health and Memory Centre
Kelowna, Canada Recruiting -
Alpha Recherche Clinique - Lévis
Lévis, Canada Recruiting -
The Fe/Male Health Centre
Oakville, Canada Recruiting -
Alpha Recherche Clinique
Québec, Canada Recruiting -
ALPHA Recherche Clinique
Québec, Canada Recruiting -
CaRe Clinic
Red Deer, Canada Recruiting -
Sunnybrook Research Institute
Toronto, Canada Recruiting -
Peking University People's Hospital
Beijing, China Recruiting -
Xuanwu Hospital Capital Medical University
Beijing, China Recruiting -
Peking University Third Hospital
Beijing, China Recruiting -
Peking University First Hospital
Beijing, China Recruiting -
Sichuan Provincial People's Hospital
Chengdu, China Recruiting -
Chengdu Women and Children Center Hospital
Chengdu, China Recruiting -
2nd Affiliated Hospital Chongqing Medical University
Chongqing, China Recruiting -
Zhujiang Hospital
Guangzhou, China Recruiting -
The First Affiliated Hospital of Jinan University
Guangzhou, China Recruiting -
Zhejiang Provincial People's Hospital
Hangzhou, China Recruiting -
Second Affiliated hospital of Anhui Medical University
Hefei, China Recruiting -
Gansu Provincial Hospital
Lanzhou, China Recruiting -
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, China Recruiting -
Ningbo First Hospital
Ningbo, China Recruiting -
Obstetrics & Gynecology Hospital of Fudan University
Shanghai, China Recruiting -
Peking University Shenzhen Hospital
Shenzhen, China Recruiting -
The Second Affiliated Hospital of Soochow University
Suzhou, China Recruiting -
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, China Recruiting -
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China Recruiting -
The First Affiliated hospital of Xiamen University
Xiamen, China Recruiting -
Hasegawa Hospital - Arakawa
Arakawa City, Japan Recruiting -
Takasu Nephrology and Urology Clinic
Chiba, Japan Recruiting -
Yotsuya Medical Cube
Chiyoda City, Japan Recruiting -
St. Luke's International Hospital
Chūōku, Japan Recruiting
+70 more sites. See ClinicalTrials.gov for the full list.
Study contacts
- Study coordinator: Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
- Email: LillyTrials@Lilly.com
- Phone: 317-615-4559
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Telerehabilitation for Women with Urinary Incontinence
This study is testing if online rehabilitation programs can help women in Greece with urinary incontinence feel better compared to traditional therapy and no support at all.
-
Using TENS for pain relief during outpatient urethral bulking in women with stress urinary incontinence.
This study is testing if using a TENS machine can help reduce pain for women undergoing a specific procedure for stress urinary incontinence.
-
Adjustable Continence Therapy for treating female stress urinary incontinence
This study is testing a new treatment called Adjustable Continence Therapy to see if it can help women with stress urinary incontinence who haven't had success with other treatments.
-
See if increasing running cadence helps stress urinary incontinence in parous runners
This study tests whether increasing running cadence by about 10% for eight weeks can reduce stress urinary incontinence symptoms in parous women who run regularly and own a Garmin watch.
-
Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking
We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.
-
Evaluating the impact of different mesh widths in surgery for urinary incontinence
This study is testing whether using a wider surgical mesh during surgery for urinary incontinence in women can lead to better results and fewer problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.